Emmanuel Blin named Chairman of the Board at Noona Healthcare
Helsinki, Finland: 19 October 2017 - Noona Healthcare has appointed Emmanuel Blin to the position of Chairman of the Board as of 18.10.2017. He will work closely with Noona management and board members to implement the company's growth strategy and internationalization plans.
Emmanuel Blin has an extensive background in the pharmaceutical industry that spans multiple positions across the globe. After a global career in BMS that included roles in CEE, France, Japan, and the US, he became SVP of BMS and co headed its commercial organization. Emmanuel Blin has also subsequently been appointed Chief Strategy Officer for the company. He became deeply involved in oncology over the last 4 years as BMS began gearing up its Immuno oncology franchise.
More info on Noona's website.
Next > Sequana Medical announces results of the MOSAIC trial data presented at 2017 AASLD
Previous > iSTAR Medical completes enrolment of first-in-human MIGS trial